<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372569">
  <stage>Registered</stage>
  <submitdate>28/04/2017</submitdate>
  <approvaldate>22/05/2017</approvaldate>
  <actrnumber>ACTRN12617000748314</actrnumber>
  <trial_identification>
    <studytitle>Dark chocolate flavanols and cognition, FlaSeCo-study</studytitle>
    <scientifictitle>Dark chocolate flavanols and their effect on cognition in older people. FlaSeCo-study, RCT</scientifictitle>
    <utrn />
    <trialacronym> FlaSeCo-Trial</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Prevention of impairment in cognition of older adults</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>FlaSeCo-trial. Participants eat dark chocolate 50 g per day eight weeks time period. Chocolate in intervention group consists flavanols 400 mg per 50 grams and in control group less than 100 mg flavanols per 50 g. Participants keep diary by ticking with "x" after they had eaten their daily chocolate. Possible uneaten chocolate will be brought back at the end of intervention.</interventions>
    <comparator>Participants in control group eat eight weeks dark chocolate 50 g per day. Chocolate consists less than 100 mg flavanols per 50 g . </comparator>
    <control>Dose comparison</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Verbal flow, assessment of cognition</outcome>
      <timepoint>Baseline and eight weeks after randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Trail making test (TMT), assessment of cognition</outcome>
      <timepoint>Baseline and eight weeks after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Food and nutrient intake, 3-day food diary</outcome>
      <timepoint>Baseline and eight weeks after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Parts of CERAD, assessment of cognition</outcome>
      <timepoint>Baseline and eight weeks after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>15D, assessment of quality of life</outcome>
      <timepoint>Baseline and after eight weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood lipids (total cholesterol, LDL, HDL, triglycerides) from blood samples</outcome>
      <timepoint>Baseline and after eight weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood glucose (fasting)</outcome>
      <timepoint>Baseline and after eight weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>GDS-30, depression scale</outcome>
      <timepoint>Baseline and after eight weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>65 -75 years of age and informed consent</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria> BMI&gt;32, smoking, use of statins. medication for hypertension
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/08/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Finland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Society for Gerontological Nutrition in Finland</primarysponsorname>
    <primarysponsoraddress>Malmin kauppatie 26, 00700 Helsinki</primarysponsoraddress>
    <primarysponsorcountry>Finland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fazer</fundingname>
      <fundingaddress>Fazerintie 6
01230 Vantaa
</fundingaddress>
      <fundingcountry>Finland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of the study is to explore the effect of cacao flavanols on cognition among older people (65-75 years) who have not been diagnosed any severe medical condition and has normal cognition. In addition, the changes in participants blood glucose and lipids will be analysed. 

The study is double blinded randomized controlled trial. Participants in the intervention group receive daily 50 grams dark chocolate that rich in flavanols, especially epicathecin. Control group receives 50 grams dark chocolate that is low in flavanols. Intervention lasts 8 weeks.

Participants will be recruited in the metropolitan area of Finland. Inclusion criteria is 65-75 years of age and no severe health problems. According to power calculation total number of participants is 100.

The main outcome measures are Verbal Flow (VF) and Trail Making Test (TMT). Food intake will be collected with food records for three days. Intakes of energy, nutrients and polyphenols will be assessed. Blood samples will be collected from the participants and changes in blood glucose and lipids will be measured.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Committee of Medicine</ethicname>
      <ethicaddress>Biomedicum Helsinki 2 C, Tukholmankatu 8 C, PL 705, 00029 HUS</ethicaddress>
      <ethicapprovaldate>3/04/2017</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Finland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Merja Suominen</name>
      <address>Society for Gerontological Nutrition in Finland, Malmin kauppatie 26, 00700 Helsinki</address>
      <phone>+358505841995</phone>
      <fax />
      <email>merja.suominen@gery.fi</email>
      <country>Finland</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Merja Suominen</name>
      <address>Society for Gerontological Nutrition in Finland, Malmin kauppatie 26, 00700 Helsinki</address>
      <phone>+358505841995</phone>
      <fax />
      <email>merja.suominen@gery.fi</email>
      <country>Finland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Merja Suominen</name>
      <address>Society for Gerontological Nutrition in Finland, Malmin kauppatie 26, 00700 Helsinki</address>
      <phone>+358505841995</phone>
      <fax />
      <email>merja.suominen@gery.fi</email>
      <country>Finland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone>+358505841995</phone>
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>